|
" The pharmaceutical industry in Britain and France, 1919-1939. "
Robson, M.
| Document Type
|
:
|
Latin Dissertation
|
| Record Number
|
:
|
1093935
|
| Doc. No
|
:
|
TLets309542
|
| Main Entry
|
:
|
Robson, M.
|
| Title & Author
|
:
|
The pharmaceutical industry in Britain and France, 1919-1939.\ Robson, M.
|
| College
|
:
|
London School of Economics and Political Science (University of London)
|
| Date
|
:
|
1993
|
| student score
|
:
|
1993
|
| Degree
|
:
|
Ph.D.
|
| Abstract
|
:
|
This thesis describes the development of the pharmaceutical industry in Britainand France, focusing on the experience of individual firms during the inter war period.The resulting synthesis uses material from economic, technological, medical, social andbusiness history traditions to create a picture of the forces affecting the performance ofbusinesses in the two countries. It draws, in particular, on archival records from threecompanies - Burroughs Welicome, RhOne-Poulenc and Sandoz - which operated inBritain or France (or both), and which had made a commitment to research-basedproducts. This is supported by other archival material and a review of publishedarchivally-based studies on pharmaceutical companies (and other secondary sources) aswell as contemporary trade and professional journals, and institutional archives includingthe Medical Research Council in Britain, and the Institut Pasteur and the LaboratoireNational de Contrôle du Médicament in France. The structure holds both thematicchapters (on sizes and types of company, the medical context, and the institutional andregulatory context) and company-specific chapters.The key findings concern the widely different origins of the firms operating withinthe industry, the impact of the different legal framework governing the two markets, thechanging nature of the marketing of pharmaceuticals during the period, and the adoptionof diverse research and development strategies by companies in the two markets. Thedetailed case study research shows pharmaceutical companies playing an increasinglyactive role in trying to influence institutions, and the medical profession in both countriesduring the 1920s and 1930s. It also demonstrates the interplay between academicinstitutions and company research and development staff in work on new medicines.The main contribution of this thesis comes from the broad range of sources usedand the way that new company sources are integrated with existing material to providea comprehensive company-based account of the development of a sector of economicactivity.
|
| Subject
|
:
|
Economics economic theory
|
| Added Entry
|
:
|
London School of Economics and Political Science (University of London)
|
| |